IP Library Granted Patent US 7,152,605
Granted Patent B2
US 7,152,605 · App. 10/441,492 · Granted Dec 26, 2006

Adjustable left atrial appendage implant deployment system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,152,605
App. No.
10/441,492
Granted
Dec 26, 2006
Kind
B2
Abstract

Disclosed is an adjustable occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device is removably carried by a deployment catheter. The device may be enlarged or reduced to facilitate optimal placement or removal. Methods are also disclosed.

Claims (55)

1. An implantable device implantation system, comprising:

a deployment catheter, having an elongate flexible body with a proximal end and a distal end;

an antirotation lock on the distal end of the body;

a core extending axially through the body; and

a radially expandable implant adapted to matingly engage the antirotation lock on the distal end of the body, wherein the antirotation lock comprises an axial extension, and wherein the axial extension matingly engages with a complementary recess on the implant.

2. An implantable device implantation system as in claim 1 , wherein the axial extension is laterally offset.

3. An implantable device implantation system, comprising:

a deployment catheter, having an elongate flexible body with a proximal end and a distal end;

an antirotation lock on the distal end of the body;

a core extending axially through the body; and

a radially expandable implant adapted to matingly engage the antirotation lock on the distal end of the body, wherein the antirotation lock comprises an axial recess, and wherein the axial recess matingly engages with a complementary extension on the implant.

4. An implantable device implantation system as in claim 3 , wherein the axial recess is laterally offset.

5. An implantable device implantation system as in claim 3 , further comprising a releasable lock for releasably attaching the implant to a deployment line.

6. An implantable device implantation system, comprising:

a deployment catheter, having an elongate flexible body with a proximal end and a distal end;

an antirotation lock on the distal end of the body;

a core extending axially through the body; and

a radially expandable implant adapted to matingly engage the antirotation lock on the distal end of the body, wherein the antirotation lock comprises at least one projection, and wherein the at least one projection matingly engages with a complementary recess corresponding to the at least one projection on the implant.

7. An implantable device implantation system as in claim 6 , wherein the projection comprises an axially extending pin.

8. An implantable device implantation system as in claim 6 , wherein the projection comprises an axially extending spline.

9. An implantable device implantation system, comprising:

a deployment catheter, having an elongate flexible body with a proximal end and a distal end;

an antirotation lock on the distal end of the body;

a core extending axially through the body; and

a radially expandable implant adapted to matingly engage the antirotation lock on the distal end of the body, wherein the implant comprises at least one projection, and wherein the at least one projection matingly engages with a complementary recess corresponding to the at least one projection on the antirotation lock.

10. An implantable device implantation system as in claim 9 , wherein the projection comprises an axially extending pin.

11. An implantable device implantation system as in claim 9 , wherein the projection comprises an axially extending spline.

12. An implantation system, comprising:

an implantable device having a proximal end and a distal end and a plurality of supports extending from the proximal end to the distal end, the implantable device being movable between a reduced cross section and an enlarged cross section, wherein the implantable device comprises tissue attachment elements;

a core threadingly engageable with an internally threaded portion of the implantable device and extending proximally therefrom, wherein the core extends through the implantable device and is adapted to apply a distal force to the device to maintain the device in its reduced cross section; and

a barrier on at least a proximal face of the device.

13. An implantation system as in claim 12 , wherein the implantable device is self-expanding.

14. An implantation system as in claim 12 , wherein the implantable device includes a hub that is internally threaded.

15. An implantation system as in claim 14 , wherein the hub is a proximal hub, and a plurality of supports extend distally therefrom.

16. An implantation system as in claim 12 , further comprising a deployment catheter, having an elongate flexible body with a proximal end and a distal end, and wherein the core axially extends through the body.

17. An implantation system as in claim 12 , wherein the implantable device is sized and configured to be positioned in a left atrial appendage.

18. An implantation system as in claim 12 , wherein the barrier comprises ePTFE.

19. A system for containing embolic material within a left atrial appendage, comprising:

a deployment catheter having an inner lumen extending longitudinally therethrough;

a closure device having a proximal end, a distal end, and an intermediate portion positioned between said proximal and distal ends, said closure device having a collapsed configuration and an expanded configuration, said intermediate portion having a radially expanded dimension when said closure device is in said expanded configuration, said radially expanded dimension being sized for engaging an inner surface at the left atrial appendage;

the closure device further comprising a barrier provided along a region of said intermediate portion, said barrier being sized and configured to at least partially block an opening to the left atrial appendage, wherein said barrier is configured to promote tissue ingrowth; and

a line sized to slidably extend proximally from the closure device through said inner lumen, said line being releasably attached to said closure device, wherein said line engages said proximal and distal ends of said closure device;

wherein said barrier is provided along a proximal face of said closure device.

20. The system of claim 19 , wherein said barrier comprises a mesh fabric.

21. The system of claim 19 , wherein said intermediate portion has a maximum expanded diameter in the range of about 1 cm to about 5 cm.

22. The system of claim 19 , further comprising at least one retention element disposed at least along said intermediate portion, said retention element being configured for engaging the inner surface of the left atrial appendage when said closure device is in said expanded configuration.

23. The system of claim 22 , wherein said retention element is a barb.

24. The system of claim 19 , wherein said intermediate portion of said closure device comprises a plurality of spokes extending between said proximal and distal ends.

25. The system of claim 24 , wherein said spokes are configured to bend radially outward for engagement with the inner surface of the left atrial appendage, said spokes being caused to bend radially outward by relative movement of said proximal and distal ends.

26. The system of claim 19 , wherein said barrier is configured for facilitating cellular in-growth when said closure device is engaging the inner surface at the left atrial appendage.

27. The system of claim 19 , wherein said intermediate portion is sized to engage tissue within the left atrial appendage when said closure device is in said expanded configuration.

28. The system of claim 19 , wherein said barrier is provided at least on an exterior surface of said intermediate portion.

29. The system of claim 19 , wherein said closure device has a substantially spherical shape when in said expanded configuration.

30. The system of claim 19 , wherein an entire length of said intermediate portion between the proximal and distal ends is greater in cross-sectional area than said proximal and distal ends when said closure device is in the expanded configuration.

31. The system of claim 19 , wherein said intermediate portion has a maximum transverse dimension in the expanded configuration at about a region of the closure device that engages tissue at the left atrial appendage.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2017
From: ATRITECH, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 042285/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2007
From: EV3 ENDOVASCULAR, INC.
To: ATRITECH, INC.
Reel/Frame 019714/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2006
From: EV3 SUNNYVALE, INC.
To: EV3 ENDOVASCULAR, INC.
Reel/Frame 018026/0660 →